APA (7th ed.) Citation

Pasquau, J., de Jesus, S. E., Arazo, P., Crusells, M. J., Ríos, M. J., Lozano, F., . . . Group, R. S. (2019). Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment-experienced patients with advanced HIV infection: A preliminary 24 week analysis (RIDAR study). BMC Infectious Diseases, 19(1), N.PAG. https://doi.org/10.1186/s12879-019-3817-6

Chicago Style (17th ed.) Citation

Pasquau, Juan, et al. "Effectiveness and Safety of Dual Therapy with Rilpivirine and Boosted Darunavir in Treatment-experienced Patients with Advanced HIV Infection: A Preliminary 24 week Analysis (RIDAR Study)." BMC Infectious Diseases 19, no. 1 (2019): N.PAG. https://doi.org/10.1186/s12879-019-3817-6.

MLA (9th ed.) Citation

Pasquau, Juan, et al. "Effectiveness and Safety of Dual Therapy with Rilpivirine and Boosted Darunavir in Treatment-experienced Patients with Advanced HIV Infection: A Preliminary 24 week Analysis (RIDAR Study)." BMC Infectious Diseases, vol. 19, no. 1, 2019, p. N.PAG, https://doi.org/10.1186/s12879-019-3817-6.